The Soluble Isoform of CTLA-4 Correlates with Interferon-α Activity in Systemic Lupus Erythematosus

REFERENCES

1. 1.↵
   1. Liu Z,
   2. Davidson A

   . Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 2012;18:871–82.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Wei SC,
   2. Duffy CR,
   3. Allison JP

   . Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov 2018;8:1069–86.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Oaks MK,
   2. Hallett KM,
   3. Penwell RT,
   4. Stauber EC,
   5. Warren SJ,
   6. Tector AJ

   . A native soluble form of CTLA-4. Cell Immunol 2000;201:144–53.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Wong CK,
   2. Lit LC,
   3. Tam LS,
   4. Li EK,
   5. Lam CW

   . Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology 2005;44:989–94.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Lenschow DJ,
   2. Zeng Y,
   3. Thistlethwaite JR,
   4. Montag A,
   5. Brady W,
   6. Gibson MG,
   7. et al.

   Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 1992;257:789–92.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Dahal LN,
   2. Basu N,
   3. Youssef H,
   4. Khanolkar RC,
   5. Barker RN,
   6. Erwig LP,
   7. et al.

   Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus. Arthritis Res Ther 2016;18:180.

   OpenUrl
7. 7.↵
   1. Ward FJ,
   2. Dahal LN,
   3. Wijesekera SK,
   4. Abdul-Jawad SK,
   5. Kaewarpai T,
   6. Xu H,
   7. et al.

   The soluble isoform of CTLA-4 as a regulator of T-cell responses. Eur J Immunol 2013;43:1274–85.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Ronnelid J,
   2. Tejde A,
   3. Mathsson L,
   4. Nilsson-Ekdahl K,
   5. Nilsson B

   . Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann Rheum Dis 2003;62:37–42.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Ueda H,
   2. Howson JM,
   3. Esposito L,
   4. Heward J,
   5. Snook H,
   6. Chamberlain G,
   7. et al.

   Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506–11.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Wofsy D

    . Recent progress in conventional and biologic therapy for systemic lupus erythematosus. Ann Rheum Dis 2013;72 Suppl 2:ii66–8.

    OpenUrlAbstract/FREE Full Text